Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports

被引:165
作者
Caers, J
Fontaine, C
Vinh-Hung, V
De Mey, J
Ponnet, G
Oost, C
Lamote, J
De Greve, J
Van Camp, B
Lacor, P
机构
[1] Vrije Univ Brussels, Lab Hematol Immunol, B-1090 Brussels, Belgium
[2] Free Univ Brussels, Acad Hosp, Dept Internal Med, B-1090 Brussels, Belgium
[3] Free Univ Brussels, Acad Hosp, Dept Haematol & Med Oncol, B-1090 Brussels, Belgium
[4] Free Univ Brussels, Acad Hosp, Dept Radiat Therapy, B-1090 Brussels, Belgium
[5] Free Univ Brussels, Acad Hosp, Dept Radiol, B-1090 Brussels, Belgium
[6] Free Univ Brussels, Acad Hosp, Dept Surg Oncol, B-1090 Brussels, Belgium
关键词
complications; infusion ports; risk factor; thrombosis;
D O I
10.1007/s00520-004-0723-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims: The use of subcutaneous infusion ports has become standard practice to provide a long-term venous access in oncological patients. The aim of this retrospective study was to assess the different complications of infusion ports in our population and to identify predisposing factors. Patients and methods: We reviewed the medical records of 437 patients who were followed at the Oncology/Haematology Department of our hospital. Of these patients, there were 370 (84.4%) with solid tumours and 58 (13.2%) with haematological disease. The position of the catheter tip was evaluated by reviewing the available chest radiographs or phlebographies. Main results: Analysis of the records showed that 346 patients (79.17%) had no complications. The most common complications after implantation were thrombosis (8.46%), catheter dysfunction (4.8%) and infections (4.4%). Univariate and multivariate analysis showed that catheter tip positioning was the most important predisposing risk factor for thrombosis. Catheter tips positioned in the brachiocephalic vein or in the cranial part of the superior vena cava were associated with a high risk of thrombosis. Other significant risk factors were gender and initial diagnosis. Female patients and patients with lung cancer also had an elevated risk of developing a thrombosis. Conclusions: Compared to other reports, we noted a higher rate of thrombosis and port dysfunction. Since catheter tip position was a predisposing factor for developing a thrombosis, correct catheter position has to be ensured during placement. Prophylactic antithrombotic treatment might be beneficial in the event of failure to position the catheter correctly.
引用
收藏
页码:325 / 331
页数:7
相关论文
共 33 条
[1]   THROMBOSIS - THE MAJOR HICKMAN CATHETER COMPLICATION IN PATIENTS WITH SOLID TUMOR [J].
ANDERSON, AJ ;
KRASNOW, SH ;
BOYER, MW ;
CUTLER, DJ ;
JONES, BD ;
CITRON, ML ;
ORTEGA, LG ;
COHEN, MH .
CHEST, 1989, 95 (01) :71-75
[2]  
BARRIOS CH, 1992, ONCOLOGY, V49, P474
[3]   VERY LOW-DOSES OF WARFARIN CAN PREVENT THROMBOSIS IN CENTRAL VENOUS CATHETERS - A RANDOMIZED PROSPECTIVE TRIAL [J].
BERN, MM ;
LOKICH, JJ ;
WALLACH, SR ;
BOTHE, A ;
BENOTTI, PN ;
ARKIN, CF ;
GRECO, FA ;
HUBERMAN, M ;
MOORE, C .
ANNALS OF INTERNAL MEDICINE, 1990, 112 (06) :423-428
[4]   Totally implantable central venous access ports for long-term chemotherapy - A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days [J].
Biffi, R ;
de Braud, E ;
Orsi, E ;
Pozzi, S ;
Mauri, S ;
Goldhirsch, A ;
Nole, F ;
Andreoni, B .
ANNALS OF ONCOLOGY, 1998, 9 (07) :767-773
[5]   Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies [J].
Boraks, P ;
Seale, J ;
Price, J ;
Bass, G ;
Ethell, M ;
Keeling, D ;
Mahendra, P ;
Baglin, T ;
Marcus, R .
BRITISH JOURNAL OF HAEMATOLOGY, 1998, 101 (03) :483-486
[6]  
Brown-Smith J K, 1990, Oncol Nurs Forum, V17, P543
[7]  
CHEVREL JP, 1988, PRESSE MED, V17, P17
[8]   A RARE COMPLICATION OF IMPLANTED CENTRAL-VENOUS ACCESS DEVICES - CATHETER FRACTURE AND EMBOLIZATION [J].
DEBETS, JMH ;
WILS, JAMJ ;
SCHLANGEN, JT .
SUPPORTIVE CARE IN CANCER, 1995, 3 (06) :432-434
[9]   Central venous thrombosis: An early and frequent complication in cancer patients bearing long-term silastic catheter. A prospective study [J].
DeCicco, M ;
Matovic, M ;
Balestreri, L ;
Panarello, G ;
Fantin, D ;
Morassut, S ;
Testa, V .
THROMBOSIS RESEARCH, 1997, 86 (02) :101-113
[10]   ANTITHROMBIN-III DEFICIENCY AS A RISK FACTOR FOR CATHETER-RELATED CENTRAL VEIN-THROMBOSIS IN CANCER-PATIENTS [J].
DECICCO, M ;
MATOVIC, M ;
BALESTRERI, L ;
DEANGELIS, V ;
FRACASSO, A ;
MORASSUT, S ;
CORAN, F ;
BABARE, R ;
BUONADONNA, A ;
TESTA, V .
THROMBOSIS RESEARCH, 1995, 78 (02) :127-137